The role of the thyroid hormone in the effect of p-chlorophenoxyisobutyrate in rats
- 1 June 1968
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 17 (6), 1003-1016
- https://doi.org/10.1016/0006-2952(68)90359-6
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RATNature, 1965
- Studies with ethyl chlorophenoxyisobutyrate (clofibrate)Metabolism, 1965
- Effects of α-p-chlorophenoxyisobutyryl ethyl ester (CPIB) with and without androsterone on cholesterol biosynthesis in rat liverJournal of Lipid Research, 1965
- Effect of p-chlorophenoxyisobutyric acid, ethyl p-chlorophenoxyisobutyrate, and Atromid on the synthesis of nonsaponifiable material and cholesterol in the bovine aortaBiochemical Pharmacology, 1965
- Reduction of serum triglycerides and cholesterol by ethyl p-chlorophenoxyisobutyrate (CPIB)The American Journal of Cardiology, 1965
- Biochemical aspects of toxicology of atromidJournal of Atherosclerosis Research, 1963
- Experimental studies of the toxicity of atromid with particular reference to fine structural changes in the livers of rodentsJournal of Atherosclerosis Research, 1963
- Studies on low-density lipoprotein turnover in relation to atromid therapyJournal of Atherosclerosis Research, 1963
- Observations upon the metabolic effects of atromidJournal of Atherosclerosis Research, 1963
- EXPERIMENTAL EVALUATION OF AN ORALLY ACTIVE COMBINATION OF ANDROSTERONE WITH ETHYL CHLOROPHENOXYISOBUTYRATEThe Lancet, 1962